High grade squamous intraepithelial lesion (HSIL)
Showing 1 - 25 of >10,000
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Anal Tumor Trial in Chicago, New York, Québec (VGX-3100, CELLECTRA™ 5PSP)
Completed
- Anal Neoplasm
- VGX-3100
- CELLECTRA™ 5PSP
-
Chicago, Illinois
- +2 more
Dec 6, 2021
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN) Trial in
Completed
- Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
- +6 more
- VGX-3100
- +2 more
-
Newark, Delaware
- +14 more
Dec 6, 2021
High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])
Active, not recruiting
- High Grade Squamous Intra-epithelial Lesion (HSIL)
- Pomalidomide 2 MG Oral Capsule [Pomalyst]
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
Mar 28, 2022
Anal High Grade Squamous Intraepithelial Lesion Trial in New York, Houston (mHRME (Mobile High resolution microendoscope))
Recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- mHRME (Mobile High resolution microendoscope)
-
New York, New York
- +1 more
Sep 7, 2021
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Tucson, Arizona
- +52 more
Oct 13, 2022
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Mesa, Arizona
- +59 more
Dec 6, 2021
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,
Recruiting
- AIDS-Related Anal Carcinoma
- +4 more
- Biopsy
- +5 more
-
San Francisco, California
- +2 more
Jan 24, 2023
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023
HPV Infection, HSIL, High-Grade Squamous Intraepithelial Lesions, Viral Load Trial in China (Follow-up)
Recruiting
- HPV Infection
- +2 more
- Follow-up
-
Fuzhou, Fujian, China
- +9 more
Mar 7, 2022
Human Papillomavirus Infection Trial in Pathum Wan (SEARCH010/RV254)
Active, not recruiting
- Human Papillomavirus Infection
- SEARCH010/RV254
-
Pathum Wan, Bangkok, ThailandThe Thai Red Cross AIDS Research Centre
Apr 21, 2022
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.
Recruiting
- AIN3
- +2 more
- Detection of anal HSIL in a routine colonoscopy.
-
Gondomar, Porto, PortugalFernando Pessoa Teaching Hospital
Dec 9, 2022
Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease Trial in Baltimore, Cleveland,
Active, not recruiting
- Vulvar Dysplasia
- +4 more
- artesunate ointment 40%
-
Baltimore, Maryland
- +3 more
Oct 31, 2022
Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)
Recruiting
- Papilloma Viral Infection
- +2 more
- Glizigen
- Placebo
-
Madrid, Spain
- +3 more
Jun 27, 2023
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial
Recruiting
- Vulvar Intraepithelial Neoplasia
- +2 more
- Metvixia Topical Cream
-
Vandœuvre-lès-Nancy, FranceInstitut de Cancerologie de Lorraine
Dec 3, 2021
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion Trial in Los Angeles, Oklahoma City
Recruiting
- Cervical Squamous Cell Carcinoma In Situ
- Vulvar High Grade Squamous Intraepithelial Lesion
- Cyclophosphamide
- +7 more
-
Los Angeles, California
- +1 more
Aug 19, 2022
Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)
Recruiting
- Magnetic Resonance Imaging Examination
- MRI,SCC-Ag
-
Wenzhou, Zhejiang, ChinaThe 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Aug 3, 2022
Squamous Lntraepithelial Lesions of Vulva, Tumors, Squamous Cell, Vulvar HSIL Trial run by the NCI (E7 T Cell Receptor (TCR))
Terminated
- Squamous Lntraepithelial Lesions of Vulva
- +2 more
- E7 T Cell Receptor (TCR)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 18, 2021
Prognostic Study of HPV Virus Integration in Women With HSIL
Recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, China
- +12 more
Feb 16, 2023
HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)
Recruiting
- HPV-Related Cervical Carcinoma
- +3 more
- CO2
-
Wenzhou, Zhejiang, Chinafirst affiliated hospital of Wenzhou medical university
Sep 23, 2023
Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion Trial in São Paulo, Cuernavaca (Xpert HPV, S5
Recruiting
- Cervix Cancer
- +3 more
- Xpert HPV
- S5 DNA methylation classifier
-
São Paulo, Brazil
- +1 more
Aug 14, 2023